Title:
TREATMENT OF OSTEOPOROSIS
Document Type and Number:
Japanese Patent JP2021176913
Kind Code:
A
Abstract:
To provide a pharmaceutical composition for use in the treatment of osteoporosis by oral administration of the composition.SOLUTION: The pharmaceutical composition comprises parathyroid hormone or a fragment thereof in a range of 200 to 3000 μg, at least one trypsin inhibitor, and SNAC (sodium 8-N-(2-hydroxybenzoyl)aminocaprylate) in a range of 70 to 99.4 wt%.SELECTED DRAWING: Figure 3
Inventors:
GREGORY BURSHTEIN
ARIEL ROTHNER
PHILLIP M SCHWARTZ
HILLEL GALITZER
ARIEL ROTHNER
PHILLIP M SCHWARTZ
HILLEL GALITZER
Application Number:
JP2021128281A
Publication Date:
November 11, 2021
Filing Date:
August 04, 2021
Export Citation:
Assignee:
ENTERA BIO LTD
International Classes:
A61K38/29; A61K9/20; A61K38/12; A61K38/55; A61K45/00; A61K47/16; A61P19/10; A61P43/00
Domestic Patent References:
| JP2005501852A | 2005-01-20 | |||
| JP2012500254A | 2012-01-05 | |||
| JP2007525472A | 2007-09-06 |
Foreign References:
| WO2006076692A1 | 2006-07-20 | |||
| US20050054557A1 | 2005-03-10 |
Other References:
J. BONE AND MINERAL RESEARCH, 2013, VOL.28, SUPP.SUPPL.1, P.S68, ASBMR 2013 ANNUAL MEETING, ABSTRACT, JPN6019039459, ISSN: 0004868387
CLIN. PHARMACOKINET., 2013, VOL.52, PP.995-1004, JPN6020037267, ISSN: 0004868388
CLIN. PHARMACOKINET., 2013, VOL.52, PP.995-1004, JPN6020037267, ISSN: 0004868388
Attorney, Agent or Firm:
Washeda International Patent Office